Phase II study of second-line treatment with high-dose cyclophosphamide in recurrent metastatic breast cancer

1996 ◽  
Vol 37 (4) ◽  
pp. 377-381
Author(s):  
Flemming Hansen ◽  
Peter Møller ◽  
Torben Skovsgaard
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
High Dose ◽  
Line Treatment ◽  
Second Line

Phase II study of cabazitaxel as second-line treatment in patients with HER-2 negative metastatic breast cancer previously treated with taxanes.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 1089-1089
Author(s):  
Angelos Koutras ◽  
Flora Zagouri ◽  
Georgia-Angeliki Koliou ◽  
Georgios Lazaridis ◽  
Dimitrios Tryfonopoulos ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Line Treatment ◽  
Second Line ◽  
Previously Treated ◽  
Her 2

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study

2003 ◽  
Vol 52 (2) ◽  
pp. 147-152 ◽  
Author(s):  
Michela Donadio ◽  
Mara Ardine ◽  
Alfredo Berruti ◽  
Giuliana Ritorto ◽  
Elena Fea ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Line Treatment ◽  
Second Line

Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study

2010 ◽  
Vol 10 (4) ◽  
pp. 313-317 ◽  
Author(s):  
Juan de la Haba-Rodriguez ◽  
Rosario González Mancha ◽  
Gumersindo Pérez Manga ◽  
Enrique Aranda Aguilar ◽  
José Manuel Baena Cañada ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document